SLNCF: Silence Therapeutics plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,008.72
Enterprise Value ($M) n/a
Book Value ($M) 134.02
Book Value / Share 0.95
Price / Book n/a
NCAV ($M) 118.75
NCAV / Share 0.84
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.34
Return on Assets (ROA) -0.48
Return on Equity (ROE) -2.66

Liquidity (mrq)
Quick Ratio 11.14
Current Ratio 11.14

Balance Sheet (mrq) ($M)
Current Assets 187.37
Assets 202.63
Liabilities 68.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 43.26
Operating Income -49.58
Net Income -45.31

Cash Flow Statement (mra) ($M)
Cash From Operations -67.64
Cash from Investing -21.97
Cash from Financing 142.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Redmile Group, LLC 5.10
02-11 13G/A Lombard Odier Asset Management (USA) Corp 7.60 34.05
12-20 13D/A Griffiths Richard Ian 19.30 15.00
11-14 13G/A Deep Track Capital, LP 2.14 -48.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
SGFEF – Siegfried Holding AG SIGO – Sunset Island Group, Inc.
SKVI – Skinvisible, Inc. SMFL – Smart for Life, Inc.
SNNC – Sibannac, Inc.


Financial data and stock pages provided by
Fintel.io